Preoperative chemoradiation and pancreaticoduodenectomy with portal vein resection for lacalized advanced pancreatic cancer

Yoon Seok Chae, Jin Sub Choi, Kyung Sik Kim, Jinsil Seong, Woo Jung Lee, Byong Ro Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pancreatic adenocarcinoma is a common disease that is rarely cured. Surgical resection remains the only treatment modality that has a curative potential, although the majority of patients are unsuitable for resection at the time of diagnosis. Chemoradiation therapy prior to a pancreaticoduodenectomy ensures that a patient who undergoes a complete resection multimodality therapy, avoids a resection in patients who have a rapidly progressive disease, and allows radiation therapy to be given to well oxygenated cells before, surgical devasculation. This permits the chance of resection of an unresectable pancreatic cancer by downstaging. A patient with cytologic proof of localized adenocarcinoma of the pancreatic head received an intravenously chemoradiation (Taxol, 50 mg/m2 intravenously for 3 hours week on 5 cycles, of Gemcytabine 1000mg/m2/day intravenously for 3 days week on 2 cycles, of 4500 cGy) with the intention of proceeding to a resection operation, restaging was performed by computed tomography, magnetic resonance imaging from 5 weeks every months due to ongoing decreasing of tumor size after the chemoradiation. At laparotomy, the patient didn't have suspected metastatic disease, the tumor size was 2 × 3 cm on the pancreas head and was infiltrating into the portal vein for about 3 cm length on right side. A pancreaticoduodenectomy along with a portal vein and superior mesenteric vein resection was done and then reconstruction of a vascular anastomosis by using the right side of the internal jugular vein. Perioperative complications didn't occur. In conclusion, preoperative chemoradiation of a localized advanced pancreatic tumor has no added risk to the operative complications and the prospects for resectability are enhanced.

Original languageEnglish
Pages (from-to)551-556
Number of pages6
JournalYonsei medical journal
Volume44
Issue number3
DOIs
Publication statusPublished - 2003 Jun 30

Fingerprint

Pancreaticoduodenectomy
Portal Vein
Pancreatic Neoplasms
Adenocarcinoma
Mesenteric Veins
Neoplasms
Jugular Veins
Paclitaxel
Laparotomy
Blood Vessels
Pancreas
Radiotherapy
Therapeutics
Tomography
Magnetic Resonance Imaging

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Chae, Yoon Seok ; Choi, Jin Sub ; Kim, Kyung Sik ; Seong, Jinsil ; Lee, Woo Jung ; Kim, Byong Ro. / Preoperative chemoradiation and pancreaticoduodenectomy with portal vein resection for lacalized advanced pancreatic cancer. In: Yonsei medical journal. 2003 ; Vol. 44, No. 3. pp. 551-556.
@article{db5faec6e1fd4b879aa192bbe0c59ba0,
title = "Preoperative chemoradiation and pancreaticoduodenectomy with portal vein resection for lacalized advanced pancreatic cancer",
abstract = "Pancreatic adenocarcinoma is a common disease that is rarely cured. Surgical resection remains the only treatment modality that has a curative potential, although the majority of patients are unsuitable for resection at the time of diagnosis. Chemoradiation therapy prior to a pancreaticoduodenectomy ensures that a patient who undergoes a complete resection multimodality therapy, avoids a resection in patients who have a rapidly progressive disease, and allows radiation therapy to be given to well oxygenated cells before, surgical devasculation. This permits the chance of resection of an unresectable pancreatic cancer by downstaging. A patient with cytologic proof of localized adenocarcinoma of the pancreatic head received an intravenously chemoradiation (Taxol, 50 mg/m2 intravenously for 3 hours week on 5 cycles, of Gemcytabine 1000mg/m2/day intravenously for 3 days week on 2 cycles, of 4500 cGy) with the intention of proceeding to a resection operation, restaging was performed by computed tomography, magnetic resonance imaging from 5 weeks every months due to ongoing decreasing of tumor size after the chemoradiation. At laparotomy, the patient didn't have suspected metastatic disease, the tumor size was 2 × 3 cm on the pancreas head and was infiltrating into the portal vein for about 3 cm length on right side. A pancreaticoduodenectomy along with a portal vein and superior mesenteric vein resection was done and then reconstruction of a vascular anastomosis by using the right side of the internal jugular vein. Perioperative complications didn't occur. In conclusion, preoperative chemoradiation of a localized advanced pancreatic tumor has no added risk to the operative complications and the prospects for resectability are enhanced.",
author = "Chae, {Yoon Seok} and Choi, {Jin Sub} and Kim, {Kyung Sik} and Jinsil Seong and Lee, {Woo Jung} and Kim, {Byong Ro}",
year = "2003",
month = "6",
day = "30",
doi = "10.3349/ymj.2003.44.3.551",
language = "English",
volume = "44",
pages = "551--556",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "3",

}

Preoperative chemoradiation and pancreaticoduodenectomy with portal vein resection for lacalized advanced pancreatic cancer. / Chae, Yoon Seok; Choi, Jin Sub; Kim, Kyung Sik; Seong, Jinsil; Lee, Woo Jung; Kim, Byong Ro.

In: Yonsei medical journal, Vol. 44, No. 3, 30.06.2003, p. 551-556.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preoperative chemoradiation and pancreaticoduodenectomy with portal vein resection for lacalized advanced pancreatic cancer

AU - Chae, Yoon Seok

AU - Choi, Jin Sub

AU - Kim, Kyung Sik

AU - Seong, Jinsil

AU - Lee, Woo Jung

AU - Kim, Byong Ro

PY - 2003/6/30

Y1 - 2003/6/30

N2 - Pancreatic adenocarcinoma is a common disease that is rarely cured. Surgical resection remains the only treatment modality that has a curative potential, although the majority of patients are unsuitable for resection at the time of diagnosis. Chemoradiation therapy prior to a pancreaticoduodenectomy ensures that a patient who undergoes a complete resection multimodality therapy, avoids a resection in patients who have a rapidly progressive disease, and allows radiation therapy to be given to well oxygenated cells before, surgical devasculation. This permits the chance of resection of an unresectable pancreatic cancer by downstaging. A patient with cytologic proof of localized adenocarcinoma of the pancreatic head received an intravenously chemoradiation (Taxol, 50 mg/m2 intravenously for 3 hours week on 5 cycles, of Gemcytabine 1000mg/m2/day intravenously for 3 days week on 2 cycles, of 4500 cGy) with the intention of proceeding to a resection operation, restaging was performed by computed tomography, magnetic resonance imaging from 5 weeks every months due to ongoing decreasing of tumor size after the chemoradiation. At laparotomy, the patient didn't have suspected metastatic disease, the tumor size was 2 × 3 cm on the pancreas head and was infiltrating into the portal vein for about 3 cm length on right side. A pancreaticoduodenectomy along with a portal vein and superior mesenteric vein resection was done and then reconstruction of a vascular anastomosis by using the right side of the internal jugular vein. Perioperative complications didn't occur. In conclusion, preoperative chemoradiation of a localized advanced pancreatic tumor has no added risk to the operative complications and the prospects for resectability are enhanced.

AB - Pancreatic adenocarcinoma is a common disease that is rarely cured. Surgical resection remains the only treatment modality that has a curative potential, although the majority of patients are unsuitable for resection at the time of diagnosis. Chemoradiation therapy prior to a pancreaticoduodenectomy ensures that a patient who undergoes a complete resection multimodality therapy, avoids a resection in patients who have a rapidly progressive disease, and allows radiation therapy to be given to well oxygenated cells before, surgical devasculation. This permits the chance of resection of an unresectable pancreatic cancer by downstaging. A patient with cytologic proof of localized adenocarcinoma of the pancreatic head received an intravenously chemoradiation (Taxol, 50 mg/m2 intravenously for 3 hours week on 5 cycles, of Gemcytabine 1000mg/m2/day intravenously for 3 days week on 2 cycles, of 4500 cGy) with the intention of proceeding to a resection operation, restaging was performed by computed tomography, magnetic resonance imaging from 5 weeks every months due to ongoing decreasing of tumor size after the chemoradiation. At laparotomy, the patient didn't have suspected metastatic disease, the tumor size was 2 × 3 cm on the pancreas head and was infiltrating into the portal vein for about 3 cm length on right side. A pancreaticoduodenectomy along with a portal vein and superior mesenteric vein resection was done and then reconstruction of a vascular anastomosis by using the right side of the internal jugular vein. Perioperative complications didn't occur. In conclusion, preoperative chemoradiation of a localized advanced pancreatic tumor has no added risk to the operative complications and the prospects for resectability are enhanced.

UR - http://www.scopus.com/inward/record.url?scp=0038575265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038575265&partnerID=8YFLogxK

U2 - 10.3349/ymj.2003.44.3.551

DO - 10.3349/ymj.2003.44.3.551

M3 - Article

VL - 44

SP - 551

EP - 556

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 3

ER -